Virogenomics BioDevelopment

company

About

Virogenomics BioDevelopment recognize the challenge of advancing early stage technology out of the lab and into the marketplace.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$587.39K
Industries
Biotechnology,Marketplace
Founded date
Jan 1, 2015
Number Of Employee
11 - 50
Operating Status
Active

Virogenomics BioDevelopment recognize the challenge of advancing early stage technology out of the lab and into the marketplace. Their goal is to help bridge this gap. They work with technology leaders at universities and small biotech companies to help them determine the full potential of their technology and a path forward that maximizes its impact. They have experience and expertise in bringing together the scientific, regulatory, and funding pieces that are necessary for success.



Although Virogenomics BioDevelopment is a new company, the executive team and board of directors have been focused on early stage technologies for over a decade. Located in the beautiful Pacific Northwest, the team collaborates with partners across the United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$587.39K
Virogenomics BioDevelopment has raised a total of $587.39K in funding over 2 rounds. Their latest funding was raised on Jan 1, 2018 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 1, 2018 Series Unknown 1 Detail
Mar 23, 2012 Grant $587.39K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Virogenomics BioDevelopment is funded by 2 investors. National Science Foundation and Reference Capital are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
Reference Capital Series Unknown